tiprankstipranks
Advertisement
Advertisement

GNNSF Stock Latest News

Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
Company AnnouncementsGenscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
15d ago
GenScript Associate Legend Biotech Reports Promising In Vivo CAR-T Data in B-Cell Lymphoma
PremiumCompany Announcements
GenScript Associate Legend Biotech Reports Promising In Vivo CAR-T Data in B-Cell Lymphoma
2M ago
Genscript Biotech Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
Genscript Biotech Shareholders Approve All Resolutions at 2026 AGM
2M ago
Genscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives
PremiumCompany Announcements
Genscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives
2M ago
Genscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma
PremiumCompany Announcements
Genscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma
2M ago
Genscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs
PremiumCompany AnnouncementsGenscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs
2M ago
GenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting
Premium
Company Announcements
GenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting
2M ago
Genscript flags Legend Biotech Q1 results and cautions investors on risk
Premium
Company Announcements
Genscript flags Legend Biotech Q1 results and cautions investors on risk
3M ago
Genscript Highlights Strong Q1 2026 CARVYKTI Sales via Legend Biotech
PremiumCompany Announcements
Genscript Highlights Strong Q1 2026 CARVYKTI Sales via Legend Biotech
4M ago
Genscript Biotech Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
PremiumCompany Announcements
Genscript Biotech Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
4M ago
Genscript Biotech Proposes Governance Overhaul to Align With Updated Listing Rules
PremiumCompany Announcements
Genscript Biotech Proposes Governance Overhaul to Align With Updated Listing Rules
4M ago
Genscript Biotech Names New Company Secretary and Authorised Representative
PremiumCompany Announcements
Genscript Biotech Names New Company Secretary and Authorised Representative
5M ago
Genscript Biotech’s Core Earnings Surge but Legend Impairment Drives 2025 Net Loss
PremiumCompany AnnouncementsGenscript Biotech’s Core Earnings Surge but Legend Impairment Drives 2025 Net Loss
5M ago
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
Premium
Company Announcements
Genscript flags 2025 loss on Legend impairment despite surge in licensing profit
5M ago
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
Premium
Company Announcements
Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk
5M ago
Genscript Biotech Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Genscript Biotech Sets March Board Meeting to Approve 2025 Annual Results
5M ago
Genscript Chairman Joins Board of Nasdaq-Listed Associate Legend Biotech
PremiumCompany Announcements
Genscript Chairman Joins Board of Nasdaq-Listed Associate Legend Biotech
6M ago
Genscript Highlights Strong Q4 2025 CARVYKTI® Sales Reported by Legend Biotech
PremiumCompany Announcements
Genscript Highlights Strong Q4 2025 CARVYKTI® Sales Reported by Legend Biotech
6M ago
Genscript Biotech Grants Share Awards to Directors
PremiumCompany Announcements
Genscript Biotech Grants Share Awards to Directors
8M ago
Genscript Biotech Updates RSU Schemes for Improved Governance
PremiumCompany AnnouncementsGenscript Biotech Updates RSU Schemes for Improved Governance
8M ago
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
Premium
Company Announcements
Legend Biotech Unveils Promising Data at 2025 ASH Meeting
8M ago
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
Premium
Company Announcements
Genscript Biotech Announces Q3 2025 Results for Legend Biotech
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >